Celling Biosciences, Inc.

Celling Biosciences is a biotech company focused on the science, research and development of autologous cellular therapy. Celling developed the first system on the market that allows a user to regulate and select a desired cell type through a patented collection window and integrated ultra-filtration system. The ART PLUS Family of products is the only integrated ultra-filtration system on the market that allows for the processing of bone marrow, peripheral blood and growth factors at the point of care.